Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[A CASE OF POLYMYALGIA RHEUMATICA (PMR)-LIKE irAE DEVELOPING DURING NIVOLUMAB ADMINISTRATION AFTER SURGERY FOR MUSCLE-INVASIVE BLADDER CANCER : A CASE REPORT].

Created on 04 Nov 2026

Authors

Yuriko Hayashi, Kota Iida, Kosuke Narita, Yoshitaka Itami, Yukinari Hosokawa

Published in

Hinyokika kiyo. Acta urologica Japonica. Volume 72. Issue 10. Pages 319-323.

Abstract

A 76-year-old woman with muscle-invasive bladder cancer received two courses of gemcitabine plus carboplatin (GCarbo) chemotherapy, followed by total cystectomy with bilateral ureterocutaneostomy. The pathological diagnosis was pT3. As adjuvant therapy, nivolumab was initiated. After two cycles, she was emergently admitted to our hospital because of difficulty standing. On admission, she presented with pain, stiffness, and weakness of the neck, body trunk, and proximal limb muscles. Laboratory tests revealed elevated C-reactive protein, increased erythrocyte sedimentation rate, and elevated matrix metalloproteinase-3 (MMP-3) levels, while rheumatoid factor and other autoantibodies were negative. After excluding infection, malignancy, and other rheumatic diseases, she was clinically diagnosed with polymyalgia rheumatica (PMR)-like irAE. Prednisolone (PSL) at 20 mg/day was initiated as diagnostic therapy, which led to rapid improvement in her symptoms. During tapering of PSL, relapse of PMR symptoms occurred, but subsequent maintenance with a low dose of PSL resulted in sustained remission without further recurrence.

PMID:
42977727
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 15
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement